Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms
Seug Yun Yoon, Sung-Yong Kim
Korean J Intern Med. 2023;38(6):810-817. Published online 2023 Nov 1 DOI: https://doi.org/10.3904/kjim.2023.333
Citations to this article as recorded by 
Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b
Seug Yun Yoon, Sung-Soo Yoon, Deok-Hwan Yang, Gyeong-Won Lee, Sang Kyun Sohn, Ho-Jin Shin, Sung Hwa Bae, Chul Won Choi, Eun-Ji Choi, June-Won Cheong, Soo-Mee Bang, Joon Seong Park, Yong Park, Young Hoon Park, Sung-Eun Lee
Therapeutic Advances in Hematology.2026;[Epub] CrossRef
Ropeginterferon dose-escalation strategies in polycythemia vera: a systematic review and meta-analysis
Seug Yun Yoon, Suyeon Park, Sun Young Jeong, Min-Young Lee, Kyoung Ha Kim, Namsu Lee, Jong-Ho Won, Sung-Eun Lee
BMC Cancer.2026;[Epub] CrossRef
Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis
Ammar Elgadi, Mohammed Wagealla, Tibyan Noorallah, Rayan Esmail, Shafee S. Almahi
Annals of Hematology.2026;[Epub] CrossRef
Hematologic and molecular responses to ropeginterferon alfa‐2b therapy of polycythemia vera: 48‐week results from a prospective study
Seug Yun Yoon, Sung‐Soo Yoon, Deok‐Hwan Yang, Gyeong‐Won Lee, Sang Kyun Sohn, Ho‐Jin Shin, Sung Hwa Bae, Chul Won Choi, Eun‐Ji Choi, June‐Won Cheong, Soo‐Mee Bang, Joon Seong Park, Suk Joong Oh, Yong Park, Young Hoon Park, Sung‐Eun Lee
International Journal of Cancer.2025; 157(3): 526. CrossRef
A comparative study of hematologic response to ropeginterferon alfa-2b in hydroxyurea-resistant or intolerant polycythemia vera: a real-world data-based analysis
Sung-Eun Lee, Seug Yun Yoon, Sung-Yong Kim, Soo-Mee Bang, Insoo Lee, Jihyuk Lee, Junshik Hong
Blood Research.2025;[Epub] CrossRef
Treatment with ropeginterferon alfa-2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one-year results from a phase 2 study
Seug Yun Yoon, Sung-Eun Lee
Blood Research.2024;[Epub] CrossRef
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure–activity relationship
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, Moumita Saha, Rajiv Patel
Bioorganic Chemistry.2024; 152: 107696. CrossRef